Welcome to our Clinician Spotlight series, where we feature clinicians from around the world who are making a positive change in the field of obesity medicine and science.

Today, we are highlighting Professor Alex Miras, an esteemed clinician, scientist and one of the founding doctors of Beyondbmi who has dedicated his career to advancing innovative treatments and improving patient care. Professor Miras is a highly respected leader in the medical field, with extensive experience in both research and clinical practice. He has made significant contributions to the field of obesity medicine, and his dedication to patient care has had a lasting impact on many lives. 

As one of the founding doctors of Beyondbmi, Professor Miras is a true visionary and has been instrumental in the development of Beyondbmi since its inception. He has been deeply involved in the planning, implementation and delivery of the Beyondbmi programme, which has enabled countless individuals to improve their health and well-being. In this blog, we will explore Professor Mira’s impressive career, his accomplishments, and his commitment to patient care. We hope you enjoy learning more about this incredible clinician!

Professor Miras is a highly respected and experienced clinician in the field of diabetes and obesity. He has been treating patients with type 2 diabetes for over 25 years and has seen many advances in the treatment of this condition. His latest venture has been to pioneer the use of the new dual GIP/GLP-1 agonist called Tirzepatide in the treatment of type 2 diabetes and obesity. This medication is the most potent available for the treatment of diabetes and has demonstrated impressive weight loss effects in trials.

To access experts in the field of obesity, book a free consultation today with Beyondbmi to learn more about how to gain health through the biology of weight loss. 

Professor Miras has already begun to use this medication in two of his international private patients in the Middle East, and their progress has been extremely encouraging. He will be reporting on his experience with this cutting-edge treatment in the near future, which will be invaluable in helping to advance the field of diabetes and obesity treatment.

Given his expertise, experience and pioneering use of this new medication, Professor Miras is one of the few physicians in Europe to offer this medication and is certainly deserving of a clinician spotlight. He is an inspiration to other clinicians and a beacon for patients seeking the most advanced treatments available for diabetes and obesity. 

Currently working at The University of Ulster, Professor Miras provides educational leadership and teaching alongside research. He also works clinically at the Western Health and Social Care Trust, based at Altnagelvin Hospital, Derry, where he is an important contributor to the Department of Endocrinology.

Professor Miras comes to Beyondbmi from Imperial College London, where he has served as a professor since 2002. Before that, he worked in various academic and clinical roles at the University of Toronto, the Harvard School of Public Health, and the University of Cambridge. His research has been published in some of the most prestigious journals in the world and he has been invited to speak about his work at numerous international conferences.

We are thrilled to welcome Professor Miras to Beyondbmi and look forward to the valuable contributions he will make to our research and educational initiatives. His expertise and experience in obesity and diabetes management will be an invaluable asset to Beyondbmi.

To access experts in the field of obesity, book a free consultation today with Beyondbmi to learn more about how to gain health through the biology of weight loss.